Adaptation of a Brazilian university hospital to clinical treatment of ectopic pregnancy: Lessons learned over 17 years

Abstract

AbstractObjectiveTo describe and compare the annual success rates of medical treatment in the analyzed period and to evaluate the associated factors.MethodsRetrospective study with 158 women with tubal pregnancy followed up over 17 years. Statistical analysis was performed using the Cochran‐Armitage test, the χ2 test, Mann–Whitney test, and multiple logistic regression.ResultsThe success rate was 47.4%. There was a trend of significant change in the success rate of clinical treatment over time (Z = 2.01, P = 0.044); it was associated to undergoing treatment between 2012 and 2017 (P = 0.028), the absence of abdominal pain (P = 0.020), receiving a higher dose of methotrexate (P < 0.001), and less time hospitalized (P < 0.001). In the final statistical model, we observed that receiving a higher dose of methotrexate (P = 0.025, odds ratio [OR] 1.03, 95% confidence interval [CI] 1.00–1.06), having a low serum β‐HCG concentration before treatment (P = 0.003, OR 0.87, 95% CI 0.79–0.95), and not having abdominal pain (P = 0.004, OR 4.26, 95% CI 1.61–11.28) were factors associated with a higher chance of successful clinical treatment for tubal pregnancy.ConclusionA greater chance of success was observed among women undergoing clinical treatment from 2012 onwards, who used higher doses of methotrexate, were asymptomatic at admission, and had low concentrations of β‐hCG.